BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18.08.1999

Draft Guidance for Industry on Levothyroxine Sodium; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Levothyroxine Sodium.'' The draft guidance is intended to answer questions concerning applications for orally administered levothyroxine sodium drug products.

Source: Federal Register — Food and Drug AdministrationOpen original release →